Despite Global Financial Crisis, China Pharma Market Expected To Grow At 20% Over Next Several Years
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Despite the financial downturn, IMS China recently reported a 26 percent increase in growth for China's pharmaceutical market in 2008, bringing the total size of the market to approximately $25 billion. The growth rate is expected to hold steady at around 20 percent for the next several years, according to IMS Health analysts
You may also be interested in...
China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion
SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years
China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion
SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years
Battling Negative Image Of Generics In Japan (Part 2 of 2)
[Editor's note: This is part two of a two-part feature on obstacles in promoting generics in Japan. Part one, which explored negative connotations associated with with the term "generic," appeared in PharmAsia News, March 19, 2009.]